Annual report pursuant to Section 13 and 15(d)

SEGMENTS (Tables)

v3.22.1
SEGMENTS (Tables)
12 Months Ended
Dec. 31, 2021
SEGMENTS [Abstract]  
Summarized Financial Information Concerning Reportable Segments Summarized financial information concerning reportable segments is shown in the following tables:

   

Year Ended December 31, 2021

 

 

 

ADMA

BioManufacturing

   

Plasma Collection

Centers

   

Corporate

   

Consolidated

 

 

                       

Revenues

  $ 74,935,528     $ 5,864,263     $ 142,834     $ 80,942,625  

 

                               

Cost of product revenue

    74,124,999
      5,644,342
      -
      79,769,341
 

 

                               

Loss from operations

    (29,293,309 )     (12,056,364 )     (17,024,068 )     (58,373,741 )

 

                               

Interest and other expense, net

    (218,053 )     (5,660 )     (13,050,164 )     (13,273,877 )

 

                               

Net loss

    (29,511,362 )     (12,062,024 )     (30,074,232 )     (71,647,618 )

 

                               

Capital expenditures

    4,876,983       8,634,275       -       13,511,258  

Depreciation and amortization expense

    4,217,771       1,272,397       5,334       5,495,502  

Total assets

    208,391,019       24,681,691       43,180,014       276,252,724  

 

Year Ended December 31, 2020

 

 

 

ADMA

BioManufacturing

   
Plasma Collection
Centers
   

Corporate

   

Consolidated

 

 

                       

Revenues

  $ 36,673,287     $ 5,403,662     $ 142,834     $ 42,219,783  

 

                               

Cost of product revenue

    55,908,696
      5,382,730
      -
      61,291,426
 

 

                               

Loss from operations

    (46,904,634 )     (4,410,890 )     (13,599,353 )     (64,914,877 )

 

                               

Interest and other expense, net

    (984,017 )     (7,388 )     (10,834,063 )     (11,825,468 )

 

                               

Gain on extinguishment of debt

    -
      -
      991,797       991,797  

 

                               

Net loss

    (47,888,651 )     (4,418,278 )     (23,441,619 )     (75,748,548 )

 

                               

Capital expenditures

    7,579,437       5,147,243       -       12,726,680  

Depreciation and amortization expense

    3,341,506       591,593       9,193       3,942,292  

Total assets

    140,908,957       13,102,008       53,662,429       207,673,394